121 related articles for article (PubMed ID: 3574286)
1. Selectivity of partial agonists related to oxotremorine based on differences in muscarinic receptor reserve between the guinea pig ileum and urinary bladder.
Ringdahl B
Mol Pharmacol; 1987 Apr; 31(4):351-6. PubMed ID: 3574286
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic and antimuscarinic activity of acetamides related to oxotremorine in the guinea pig urinary bladder.
Ringdahl B; Markowicz ME
J Pharmacol Exp Ther; 1987 Mar; 240(3):789-94. PubMed ID: 3559974
[TBL] [Abstract][Full Text] [Related]
3. Determination of dissociation constants and relative efficacies of oxotremorine analogs at muscarinic receptors in the guinea-pig ileum by pharmacological procedures.
Ringdahl B
J Pharmacol Exp Ther; 1984 Apr; 229(1):199-206. PubMed ID: 6707935
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
Ringdahl B; Roch M; Jenden DJ
J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
[TBL] [Abstract][Full Text] [Related]
5. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum.
Ringdahl B
J Pharmacol Exp Ther; 1985 Jan; 232(1):67-73. PubMed ID: 3965701
[TBL] [Abstract][Full Text] [Related]
7. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
Ringdahl B; Resul B; Ehlert FJ; Jenden DJ; Dahlbom R
Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
[TBL] [Abstract][Full Text] [Related]
8. Differential coupling of muscarinic M1, M2, and M3 receptors to phosphoinositide hydrolysis in urinary bladder and longitudinal muscle of the ileum of the mouse.
Tran JA; Matsui M; Ehlert FJ
J Pharmacol Exp Ther; 2006 Aug; 318(2):649-56. PubMed ID: 16675640
[TBL] [Abstract][Full Text] [Related]
9. Affinity, efficacy, and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea pig ileum.
Ringdahl B; Jenden DJ
Mol Pharmacol; 1983 Jan; 23(1):17-25. PubMed ID: 6135142
[No Abstract] [Full Text] [Related]
10. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterisation of the enantiomers of BM-5, a muscarinic partial agonist with opposed enantioselectivity between affinity and efficacy.
Sundquist S; Modiri AR; Nilsson BM; Hacksell U; Gillberg PG; Nilvebrant L
Pharmacol Toxicol; 2000 Jan; 86(1):44-50. PubMed ID: 10720106
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for affinity and efficacy of N-(4-amino-2-butynyl)succinimides at muscarinic receptors in the guinea-pig ileum and urinary bladder.
Ringdahl B
Eur J Pharmacol; 1987 Aug; 140(1):13-23. PubMed ID: 3622621
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
15. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
16. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Ladner CJ; Lee JM
Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the contractile responses and their coupling second messenger systems for muscarinic drugs in the guinea-pig ileal longitudinal muscle.
Konno F; Takayanagi I
Arch Int Pharmacodyn Ther; 1989; 301():15-29. PubMed ID: 2624513
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the antimuscarinic action of p-fluorohexahydrosiladifenidol in ileal and tracheal smooth muscle.
Ehlert FJ; Hsu JC; Leung K; Lee AG; Shehnaz D; Griffin MT
J Pharmacol Exp Ther; 2005 Feb; 312(2):592-600. PubMed ID: 15456838
[TBL] [Abstract][Full Text] [Related]
19. Antagonism by imidazoline-type drugs of muscarinic and other receptors in the guinea-pig ileum.
Salazar-Bookaman MM; Miller DD; Patil PN
Auton Autacoid Pharmacol; 2006 Jul; 26(3):267-73. PubMed ID: 16879492
[TBL] [Abstract][Full Text] [Related]
20. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
